Recalls for Magnetic Resonance Imaging

Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - FDA Evaluating the Risk of Brain Deposits With Repeated Use
07/27/2015 Medical Recall

Health care professionals should consider limiting GBCA use to clinical circumstances in which the additional information provided by the contrast is necessary.

  • Company:
    GBCA
Merit Medical Systems, Custom Procedural Trays/Kits Containing 1 percent Lidocaine HCl Injection, USP, 10mg/mL: Recall - Particulates Found in Hospira supplied Lidocaine
03/14/2014 Medical Recall

Presence of oxidized stainless steel particulate may put a patient at risk from strong magnetic field exposure such as MRI, and other adverse events resulting in serious life-threatening complications.

  • Company:
    Merit Medical
Hospira Issues A Voluntary Nationwide Recall Of One Lot Of 1% Lidocaine HCL Injection Due To The Presence Of Dark Particulate
10/04/2013 Food Recall

Hospira, Inc.(NYSE: HSP), announced today it has initiated a voluntary nationwide recall of one lot of 1% Lidocaine HCI Injection, USP, 10 mg/mL, 20 mL Multiple-dose Fliptop Vial, NDC 0409-4276-01 Lot 25-090-DK (the lot number may be followed by 01 or 02).

  • Company:
    Hospira